Trending Topics


Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

Decades of research have shown that cancer survival outcomes can vary widely depending on where patients receive care. Now, a new MSK study in JAMA Oncology explores a potential way to profile US hospitals by performance so, eventually, patients can make more informed decisions about their care. For more information and to set up interviews, email Jeanne D’Agostino at
Thursday, October 8, 2015
The US Food and Drug Administration approved the immunotherapy combination nivolumab (Opdivo®) plus ipilimumab (Yervoy®) for use in patients with metastatic melanoma. Memorial Sloan Kettering’s medical oncologist and cancer immunologist Jedd Wolchok, created and tested the combination and led the clinical trials that resulted in FDA approval. Patients who have received this new drug combination are also available for interview. For more information and to set up interviews, email Nicole McNamara at
Thursday, October 1, 2015
Memorial Sloan Kettering experts are available to comment on research presented at the 2015 European Cancer Congress, including research in immunotherapy, breast, lung, bladder, prostate, and kidney cancers, among others. For more information and to set up interviews or access photos and video, email Rebecca Williams,
Thursday, September 24, 2015
See all trending topics

Press Releases

Philip W. Kantoff, MD, has been named the new Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished leader, physician, researcher, and mentor, Dr. Kantoff served the Dana-Farber Cancer Institute and Harvard Medical School (HMS) since 1987 in a variety of capacities. He formally assumes his new position as George J. Bosl, MD, steps down from his role after 18 years.
Tuesday, November 17, 2015
Decades of research have shown that cancer survival outcomes can vary widely depending on where patients receive care. But efforts to rank hospitals by long-term survival rates have been hindered by the readily available administrative data derived from Medicare claims, which lacks information about cancer stage. Two hospitals providing equally good care may have different survival rates if one hospital treats sicker patients, for example.
Thursday, October 8, 2015
Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes promising investigators aged 45 or younger for their efforts in advancing cancer research.
Tuesday, September 29, 2015
See all press releases

On Our Blog

Our staff and volunteers do much more than care for patients’ medical needs. Here’s a list of some of the many ways we try to make people’s lives better.
Wednesday, November 25, 2015
A multicenter study led by MSK investigators has found seven subtypes based on their molecular characteristics.
Monday, November 23, 2015
The Josie Robertson Surgery Center will greatly enhance the way patients experience outpatient cancer surgery.
Friday, November 20, 2015
See all blog posts

Media Coverage

Medical oncologist Shanu Modi was inteviewed by Nature about antibody-based drugs used in breast cancer. 
Thursday, November 19, 2015
Medical oncologist Heather McArthur was interviewed by Nature about targeting the immune system to fight breast cancer. 
Thursday, November 19, 2015
Surgeon James Eastham discussed a new prostate cancer screening study in The New York Times
Wednesday, November 18, 2015
See all media coverage

For Journalists

Jeanne D'Agostino
Director, Media and Public Relations
Emily O'Donnell
Senior Communications Associate, Department of Surgery
Courtney Nowak
Senior Media Relations Associate
Caitlin Hool
Senior Media Associate
Nicole H. McNamara
Senior Media Relations Associate
Rebecca Williams
Media Associate
For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to the News@MSKCC newsletter

Our email newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign up

Unsubscribe »